| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Feb 6, 2024 | Conversion(C) | 675K | — | — | 675K |
| Feb 6, 2024 | Conversion(C) | 252K | — | — | 252K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Feb 6, 2024 | Conversion(C) | 406K | — | — | 0 |
| Feb 6, 2024 | Conversion(C) | 417K | — | — | 0 |
| Feb 6, 2024 | Conversion(C) | 445K | — | — | 0 |
| Feb 6, 2024 | Conversion(C) | 1.1M | — | — | 0 |
Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-026885) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Alto Neuroscience, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0000950170-24-026885"
Use Arkolith to summarize insider buying and selling at Alto Neuroscience, Inc. over the last 90 days and cite the filings.